Immediate Impact
3 by Nobel laureates 56 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Synthesis of chitosan/PVA/copper oxide nanocomposite using Anacardium occidentale extract and evaluating its antioxidant, antibacterial, anti-inflammatory and cytotoxic activities
2025 Standout
Works of Joe Healy being referenced
Impact of age at ivacaftor initiation on pulmonary outcomes among people with cystic fibrosis
2024
Monoamine Oxidases: Certainties and Uncertainties
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Joe Healy | 174 | 15 | 41 | 80 | 59 | 7 | 346 | |
| David R. Patek | 221 | 4 | 28 | 77 | 41 | 8 | 360 | |
| John V. Burba | 149 | 2 | 12 | 65 | 74 | 11 | 350 | |
| Erin M. G. Allen | 178 | 10 | 31 | 72 | 17 | 6 | 407 | |
| E. Philip Jesudason | 145 | 6 | 18 | 55 | 58 | 13 | 396 | |
| Alsiddig Osama | 193 | 22 | 8 | 65 | 38 | 14 | 351 | |
| Bryan Johnson | 164 | 19 | 8 | 51 | 22 | 13 | 354 | |
| Xiu Zhu Sun | 285 | 4 | 14 | 22 | 55 | 12 | 411 | |
| F. Manganaro | 146 | 6 | 31 | 95 | 8 | 12 | 328 | |
| Deyamira Matuz‐Mares | 186 | 15 | 11 | 58 | 16 | 15 | 375 | |
| Nidhi Kaur Bhatia | 127 | 71 | 21 | 35 | 11 | 330 |
All Works
Loading papers...